SIRT1 and the Clock Gene Machinery in Colorectal Cancer

REFERENCES

• Guarente, L, Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Engl J Med 2011;364:2235–2244.
   PubMed Web of Science ®Google Scholar
• Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009;9:123–128.
   PubMed Web of Science ®Google Scholar
• Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W. Negative regulation of the deacetylase SIRT1 by DBC1. Nature 2008;451: 587–590.
   PubMed Web of Science ®Google Scholar
• Edery I. Circadian rhythms in a nutshell. Physiol Genomics 2000;3:59–74.
   PubMed Web of Science ®Google Scholar
• Lowrey PL, Takahashi JS. Genetics of the mammalian circadian system: photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation. Annu Rev Genet 2000;34:533–562.
   PubMed Web of Science ®Google Scholar
• Nagoshi E, Saini C, Bauer C, Laroche T, Naef F, Schibler U. Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 2004;119:693–705.
   PubMed Web of Science ®Google Scholar
• Filipski E, King VM, Etienne MC, Li XM, Claustrat B, Granda TG. Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice. Am J Physiol Regul Integr Comp Physiol 2004;287:R844–R851.
   PubMed Web of Science ®Google Scholar
• Eide EJ, Vielhaber EL, Hinz WA, Virshup DM. The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase Iε. J Biol Chem 2002;277:17248–17254.
   PubMed Web of Science ®Google Scholar
• Smith KD, Fu MA, Brown EJ. Tim-Tipin dysfunction creates an indispensible reliance on the ATR-Chk1 pathway for continued DNA synthesis. J Cell Biol 2009;5:15–23.
   Google Scholar
• Yang X, Wood PA, Hrushesky WJ. Mammalian TIMELESS is required for ATM-dependent CHK2 activation and G2/M checkpoint control. J Biol Chem 2010;285:3030–3034.
   PubMed Web of Science ®Google Scholar
• Kemp MG, Akan Z, Yilmaz S, Grillo M, Smith-Roe SL, Kang TH, Cordeiro-Stone M, Kaufmann WK, Abraham RT, Sancar A, Unsal-Kaçmaz K. Tipin-replication protein A interaction mediates Chk1 phosphorylation by ATR in response to genotoxic stress. J Biol Chem 2010;285:16562–16571.
   PubMed Web of Science ®Google Scholar
• Unsal-Kaçmaz K, Chastain PD, Qu PP, Minoo P, Cordeiro-Stone M, Sancar A, Kaufmann WK. The human Tim/Tipin complex coordinates an Intra-S checkpoint response to UV that slows replication fork displacement. Mol Cell Biol 2007;27:3131–3142.
   PubMed Web of Science ®Google Scholar
• Asher G, Gatfield D, Stratmann M, Reinke H, Dibner C, Kreppel F, Mostoslavsky R, Alt FW, Schibler U. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008;134:317–328.
   PubMed Web of Science ®Google Scholar
• Matsuo T, Yamaguchi S, Mitsui S, Emi A, Shimoda F, Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 2003;302:255–259.
   PubMed Web of Science ®Google Scholar
• Filipski E, King VM, Li XM, Granda TG, Mormont MC, Liu X. Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 2002;94:690–697.
   PubMed Web of Science ®Google Scholar
• Hunt T, Sassone-Corsi P. Riding tandem: circadian clocks and the cell cycle. Cell 2007;129:461–464.
   PubMed Web of Science ®Google Scholar
• Wille JJ Jr. Circadian rhythm of tumor promotion in the two-stage model of mouse tumorigenesis. Cancer Lett 2003;190: 143–149.
   PubMed Web of Science ®Google Scholar
• Kondratov RV, Antoch MP. Circadian proteins in the regulation of cell cycle and genotoxic stress responses. Trends Cell Biol 2007;17:311–317.
   PubMed Web of Science ®Google Scholar
• Fang Y, Nicholl MB. Sirtuin 1 in malignant transformation: friend or foe? Cancer Lett 2011;306:10–14.
   Google Scholar
• Akao Y, Noguchi S, Iio A, Kojima K, Takagi T, Naoe T. Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells. Cancer Lett 2011;300:197–204.
   PubMed Web of Science ®Google Scholar
• Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW. Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2005;2:67–76.
   PubMed Web of Science ®Google Scholar
• Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, Kollipara R, Depinho RA, Gu Y, Simon JA, Bedalov A. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 2006;66:4368–4377.
   PubMed Web of Science ®Google Scholar
• Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, Kozaki K, Akishita M, Ouchi Y, Kaneki M. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 2006;25:176–185.
   PubMed Web of Science ®Google Scholar
• Wang C, Chen L, Hou X, Li Z, Kabra N, Ma Y, Nemoto S, Finkel T, Gu W, Cress WD, Chen J. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 2006;8:1025–1031.
   PubMed Web of Science ®Google Scholar
• Pruitt K, Zinn RL, Ohm JE, McGarvey KM, Kang SH, Watkins DN, Herman JG, Baylin SB. Inhibition of SIRT1 reactivates silenced cancer genes without loss of promoter DNA hypermethylation. PLoS Genet 2006;2:e40.
   PubMed Web of Science ®Google Scholar
• Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Norat T. Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One 2011;6:e20456.
   PubMed Web of Science ®Google Scholar
• Nakama H, Zhang B, Fukazawa K. Colorectal cancer screening under the age of 50 is less cost-effective. Cancer Invest 2002;20:290–291.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, Tran H, Ross SE, Mostoslavsky R, Cohen HY, Hu LS, Cheng HL, Jedrychowski MP, Gygi SP, Sinclair DA, Alt FW, Greenberg ME. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011–2015.
   PubMed Web of Science ®Google Scholar
• Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, Yeatman T, Coppola D, Chen J. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem 2009;284:18210–18217.
   PubMed Web of Science ®Google Scholar
• Roncoroni L, Elli L, Bardella MT, Dogliotti E, Grimoldi MG, Viaggi S, Erba E, Zunino A, Doneda L. Cytogenetic characterization and cell cycle analysis of three human colon adenocarcinoma cell lines: comparison between two- and three-dimensional cell culture systems. Cancer Invest 2010;28:7–12.
   PubMed Web of Science ®Google Scholar
• Shan BE, Wang MX, Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Cancer Invest 2009;27:604–612.
   PubMed Web of Science ®Google Scholar
• Li M, Xie J, Cheng L, Chang B, Wang Y, Lan X, Zhang D, Yin Y, Cheng N. Suppression of invasive properties of colorectal carcinoma SW480 cells by 15-hydroxyprostaglandin dehydrogenase gene. Cancer Invest 2008;26:905–912.
   PubMed Web of Science ®Google Scholar
• Fu L, Pelicano H, Liu J, Huang P, Lee CC. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002;111:41–50.
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Ansell CM, Quiton DF, Oh EY, Du-Quiton J, Hrushesky WJ. The circadian clock gene Per1 suppresses cancer cell proliferation and tumor growth at specific times of day. Chronobiol Int 2009;26:1323–1339.
   PubMed Web of Science ®Google Scholar
• Wood PA, Yang X, Taber A, Oh EY, Ansell C, Ayers SE, Al-Assaad Z, Carnevale K, Berger FG, Peña MM, Hrushesky WJ. Period 2 mutation accelerates ApcMin/+tumorigenesis. Mol Cancer Res 2008;6:1786–1793.
   PubMed Web of Science ®Google Scholar
• Im JS, Jung BH, Kim SE, Lee KH, Lee JK. Per3, a circadian gene, is required for Chk2 activation in human cells. FEBS Lett 2010;584:4731–4734.
   PubMedGoogle Scholar
• Krugluger W, Brandstaetter A, Kállay E, Schueller J, Krexner E, Kriwanek S, Bonner E, Cross HS. Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 2007;67:7917–7922.
   PubMed Web of Science ®Google Scholar
• Yang X, Wood PA, Ansell C, Hrushesky WJ. Circadian time-dependent tumor suppressor function of period genes. Integr Cancer Ther 2009;8:309–316.
   PubMed Web of Science ®Google Scholar
• Jung-Hynes B, Ahmad N. SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age-related neoplasms. FASEB J 2009;23:2803–2809.
   PubMed Web of Science ®Google Scholar
• Kojima K, Ohhashi R, Fujita Y, Hamada N, Akao Y, Nozawa Y, Deguchi T, Ito M. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochem Biophys Res Commun 2008;373:423–428.
   PubMed Web of Science ®Google Scholar
• Brooks CL, Gu W. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer 2009;9:123–128.
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009;8:712–715.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang D, Zhao Y, Tu B, Zheng Z, Wang L, Wang H, Gu W, Roeder RG, Zhu WG. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc Natl Acad Sci USA 2011;108:1925–1930.
   PubMed Web of Science ®Google Scholar
• Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008;105:13421–13426.
   PubMed Web of Science ®Google Scholar
• Yi J, Luo J. SIRT1 and p53, effect on cancer, senescence and beyond. Biochim Biophys Acta 2010;1804:1684–1689.
   PubMed Web of Science ®Google Scholar
• Fu L, Lee CC. The circadian clock: pacemaker and tumour suppressor. Nature Rev Cancer 2003;3:350–361.
   PubMed Web of Science ®Google Scholar
• Chen-Goodspeed M, Lee CC. Tumor suppression and circadian function. J Biol Rhythms 2007;22:291–298.
   PubMed Web of Science ®Google Scholar
• Lee CC. Tumor suppression by the mammalian Period genes. Cancer Causes Control 2006;17:525–530.
   PubMed Web of Science ®Google Scholar
• Wood PA, Yang X, Hrushesky WJ. Clock genes and cancer. Integr Cancer Ther 2009;8:303–308.
   PubMed Web of Science ®Google Scholar
• Hrushesky WJ, Grutsch J, Wood PA, Yang X, Oh EY, Ansell C, Kidder S, Ferrans C, Quiton DF, Reynolds J, Du-Quiton J, Levin R, Lis C, Braun D. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther 2009;8:387–397.
   PubMed Web of Science ®Google Scholar
• Firestein R, Blander G, Michan S, Oberdoerffer P, Ogino S, Campbell J, Bhimavarapu A, Luikenhuis S, de Cabo R, Fuchs C, Hahn WC, Guarente LP, Sinclair DA. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PLoS One 2008;3:e2020.
   PubMed Web of Science ®Google Scholar
• Buck E, Eyzaguirre A, Barr S, Thompson S, Sennello R, Young D, Iwata KK, Gibson NW, Cagnoni P, Haley JD. Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther 2007;6:532–541.
   PubMed Web of Science ®Google Scholar